Peter M. Pellerito of BIO to share a National Perspective on Best Practices That Support Bioscience Industry Growth at AZBio Trailblazer Awards Luncheon December 1, 2011.
The Arizona BioIndustry Association (AZBio) today announced that Peter M. Pellerito of the Biotechnology Industry Organization (BIO) will present a keynote on best practices for state bioscience industry growth at the AZBio Trailblazer Awards on December 1, 2011 as the community gathers to honor state leaders.Continue reading
“Unleashing the Promise of Biotechnology: Advancing American Innovation to Cure Disease and Save Lives” Provides Roadmap for Transformative Policy Changes
WASHINGTON, D.C. (Wednesday, June 29, 2011) – The Biotechnology Industry Organization (BIO) released today a summary of legislative proposals to reform the investment and regulatory environment for biotech innovation. These proposals are designed to unleash the innovation required to cure disease and make the U.S. healthcare system more affordable, efficient, and of higher quality, as well as to foster the development of breakthrough technologies to provide alternative energy sources, combat hunger and protect against bio-terrorism. The policy proposals, released at a press briefing at the 2011 BIO International Convention held here this week, will serve as the organization’s targeted advocacy plan in these two areas.
Press Release from BIO: The Leahy-Smith America Invents Act will benefit all sectors of U.S. economy
Washington, D.C. (June 23, 2011) – Biotechnology Industry Organization (BIO) President and CEO Jim Greenwood released the following statement on the passage of The Leahy-Smith America Invents Act, H.R. 1249, by the House of Representatives:
“Small biotechnology companies rely heavily on their patents to attract investment to fund the lengthy and expensive research and development process necessary to bring breakthrough medical therapies and other products to patients and consumers. Strong intellectual property protection is critical for these companies.
“The Leahy-Smith America Invents Act will bring our patent system into the 21st century. The improvements made by the bill will benefit all sectors of the national economy by enhancing patent quality and the efficiency, objectivity, predictability and transparency of the U.S. patent system.
BIO 2011 is just around the corner! June 27-30, 2011 in Washington, DC.
The Annual BIO International Convention is the world’s largest biotechnology gathering. Over 15,000 biotechnology, life science and industry professionals from around the world will gather to highlight the future of biotechnology at the BIO 2011 Annual International Convention in Washington D.C. from June 27 – 30, 2011.Continue reading
Here’s and update on SBIR and STTR from our friends at BIO in DC.
“Last week the cloture vote to move the SBIR bill toward final passage in the Senate failed and unfortunately the Senate is currently at an impasse.